
Fluconazole BP2013 CAS No.: 86386-73-4
We are a manufacturer based in China. We specialize in providing high-quality Fluconazole BP2013 CAS No.: 86386-73-4 for industrial clients across various sectors. Whether you need chemicals consultation or technical support, our team is here to help.
Category:Active Pharmaceutical Ingredients Own Brand:MT /MOQ:100KG /From China/ B2B only.
Introduction
Molecular Formula: C13H12F2N6O
Molecular Weight: 306.271
CAS No.: 86386-73-4
It is a fluorotriazole antifungal drug. Its antibacterial spectrum is similar to that of ketoconazole, and its antibacterial activity is stronger than that of ketoconazole. Fluconazole has strong antibacterial activity against Candida albicans, Large and Small Spores, Cryptococcus neoformans, Epidermophytes and Histoplasma capsulatus.
Description
It is a white or almost white, hygroscopic, crystalline powder, it’s slightly soluble in water, freely soluble in methanol, soluble in acetone.
Application
It is a fluorotriazole antifungal drug. Its antibacterial spectrum is similar to that of ketoconazole, and its antibacterial activity is stronger than that of ketoconazole. Its mechanism of action is to inhibit ergosterol synthase, an essential component of fungal cell membranes, hinder the synthesis of ergosterol, destroy the integrity of the fungal cell wall, and inhibit its growth and reproduction. Fluconazole has strong antibacterial activity against Candida albicans, Large and Small Spores, Cryptococcus neoformans, Epidermophytes and Histoplasma capsulatus.
Packing
25Kg per drum
Storage:
Preserve in tight containers in a dry place.
Shelf Life :
24 months from date of production when stored in good condition.
Minimum Order
One package
| Item | Content |
|---|---|
| Chemical Information | – Molecular Formula: C₁₃H₁₂F₂N₆O<br>- Molecular Weight: 306.27 |
| Appearance | White or almost white, hygroscopic crystalline powder; soluble in methanol, slightly soluble in water |
| Indications | – Candidiasis: Including oropharyngeal, esophageal, and disseminated candidiasis<br>- Cryptococcosis: Including cryptococcal meningitis<br>- Coccidioidomycosis |
| Mechanism of Action | Inhibits the synthesis of ergosterol in fungal cell membranes, disrupting the integrity of the fungal cell wall and inhibiting fungal growth and reproduction |
| Specifications | – Purity: 99.0%–101.0% on the dried basis<br>- Impurities: Individual impurity ≤0.5%, total impurities ≤1.0% |
| Storage Conditions | Store in a tightly closed container in a dry place. Shelf life is 24 months from the date of manufacture |
| Packaging | 25Kg/drum |
| Pharmacopoeia Standard | Complies with British Pharmacopoeia BP2013 |
| Adverse Reactions | – Common: Nausea, headache, rash<br>- Serious: Hepatic dysfunction, allergic reactions |
| Dosage and Administration | – Disseminated Candidiasis: Initial dose 0.4 g, followed by 0.2 g once daily<br>- Esophageal Candidiasis: Initial dose 0.2 g, followed by 0.1 g once daily |
If you're ready to take the next step, Leave your message below and we’ll reply soon. 20+ years of chemical manufacturing & export experience, a partner you can trust.



